Results 161 to 170 of about 18,984,511 (231)

Real‐Life Study on Gilteritinib‐Related Infections (GilteRInf): An Italian SEIFEM Study

American Journal of Hematology, Volume 101, Issue 10, Page 2672-2676, October 2026.
Elisa Buzzatti, Irene Terrenato, Martina Tomassi, Federica Lessi, Sara Pezone, Cristina Papayannidis, Gianluca Martini, Fabio Forghieri, Luana Fianchi, Martina Quattrone, Nicola Fracchiolla, Claudio Fozza, Michela Abbenante, Anna Lina Piccioni, Davide Facchinelli, Claudia Maria Basilico, Caterina Buquicchio, Nicola Di Renzo, Monica Piedimonte, Maria Giovanna Cefalo, Daniele Armiento, Adriano Venditti, Alessandro Busca, Francesco Marchesi, Maria Ilaria Del Principe, Livio Pagano   +25 more
wiley   +1 more source

Review Article: Immune Effector Cell‐Mediated Enterocolitis Following CAR‐T Cell Therapy—Clinical Features, Pathophysiology and Management

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 8, Page 1046-1057, October 2026.
Immune effector cell‐mediated enterocolitis is an emerging complication of CAR‐T therapy. This review summarizes its epidemiology, pathophysiology, diagnosis, endoscopic and histopathologic features, and evidence‐based management, emphasizing early recognition, multidisciplinary intervention, and step‐up therapy.
John A. Damianos, Yi Lin, Zongming Eric Chen, Kenneth J. C. Lim, Navreet M. Chowla   +4 more
wiley   +1 more source

The Gut Microbiome as a Therapeutic Target in Alopecia Areata: Not Yet Part of the Patient Treatment Plan

International Journal of Dermatology, Volume 65, Issue 10, Page 2001-2004, October 2026.
ABSTRACT Interest in the gut microbiome as a therapeutic target for treating alopecia areata (AA) has grown considerably. However, existing evidence remains limited and inconsistent. Currently, there is insufficient evidence to recommend microbiome‐directed testing and therapies to patients with AA.
Eric McMullen, Deema Abdel Hafeez, Nikhil Pai, Laurence Mainville, Shireen Dumont, Narachai Julanon, Romy Shenderey, Grace Xiong, Shahnawaz Towheed, Jeffrey Donovan   +9 more
wiley   +1 more source

Distinct T and innate-like lymphocyte reprogramming following lyophilized fecal microbiota transplantation in recurrent <i>C. difficile</i> infection. [PDF]

Gut Microbes
Gao Y, Shahbaz S, Elahi S, Monaghan TM, LFMT vs LSFF consortium, Kao D.   +5 more
europepmc   +1 more source

Systemic effects of sunlight: 10‐year review of cardiovascular, infection and cancer outcomes

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1618-1625, October 2026.
This review highlights the systemic effects of sunlight and ultraviolet radiation. While UV radiation exposure has known cutaneous risks including photoaging and skin cancer, evidence suggests potential associations with reduced all‐cause mortality, improved infectious disease outcomes and reduced blood pressure.
Jasira A. Ziglar, Rebecca L. Quiñonez, Lydiah Fridah M. Mpyisi, Indermeet Kohli, Yolanda Gilaberte, Henry W. Lim   +5 more
wiley   +1 more source

Characterization of the clade 4 non-toxigenic <i>C. difficile</i> isolate L-NTCD03 carrying the <i>cfr</i>(B) gene. [PDF]

FEMS Microbes
Nibbering B, Nooij S, Harmanus C, Sanders IMJG, Miedema IM, Ducarmon QR, Vossen RHAM, Kloet SL, Ardis CK, Britton RA, Yousefi F, Bayne J, Charavaryamath C, Law A, Murphy ML, Sponseller B, Burrough ER, Ramirez A, Mooyottu S, Opriessnig T, Kuijper EJ, Roestenberg M, Smits WK.   +22 more
europepmc   +1 more source

Faecal Microbiota Transplantation Reduces Lesion Severity and Medication Use in Canine Atopic Dermatitis: A Randomised, Placebo‐Controlled, Double‐Blinded Clinical Trial

Veterinary Dermatology, Volume 37, Issue 5, Page 735-744, October 2026.
Background: Faecal microbiota transplantation (FMT) is an established therapy for gastrointestinal disease, yet its role in canine atopic dermatitis (cAD) remains unclear. Hypothesis/Objectives: We hypothesised that adjunctive FMT improves clinical severity and reduces symptomatic medication use in dogs with cAD.
Vera Felten, Erin Asley West, Franco Martini, Claude Favrot, Stefan Unterer, Jan Suchodolski, Michael Scharl, Harald Renz, Nina Maria Fischer, Ana Rostaher   +9 more
wiley   +1 more source

Development of a high-throughput screening platform for <i>C. difficile</i> toxin synthesis inhibitors unveils meclizine as an antivirulence agent. [PDF]

Antimicrob Agents Chemother
Marreddy RKR, Nguyen N, Dureja C, McKelvey AM, Powell R, Olaitan AO, Stephan C, Hurdle JG.   +7 more
europepmc   +1 more source

Untersuchung von Anti‐Glykan‐Antikörpern und Erforschung ihres medizinischen Potenzials mithilfe synthetischer Glykane

Angewandte Chemie, Volume 138, Issue 39, 21 September 2026.
Anti‐Glykan‐Antikörper spielen sowohl bei Gesundheit als auch bei Krankheit eine wesentliche Rolle. Der Zugang zu neuartigen Glykanstrukturen ermöglicht Fortschritte bei der Antikörpercharakterisierung für die Entdeckung von Biomarkern, die Antikörperentwicklung und das Impfstoffdesign.
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source

Association between postdischarge antibiotic use and <i>C. difficile</i> testing as a surrogate for clinically significant diarrhea. [PDF]

Antimicrob Steward Healthc Epidemiol
Livorsi DJ, Merchant J, Cho H, Goetz MB, Alexander B, Goto M.   +5 more
europepmc   +1 more source